CBIC determines rate of exchange of conversion of the foreign currencies relating to imported and exported goods
The Central Board of Indirect Taxes and Customs has determined the rate of exchange of conversion of each of the foreign currencies into Indian currency or vice versa. The notified rates of exchange shall will come into effect from 6th January, 2023. This rate of exchange of conversion of the foreign currencies relates to imported and exported goods.
SEBI notifies Relaxations from Compliance with certain provisions of the SEBI (LODR) Regulations, 2015
The notification provides for relaxation for companies for conducting Extraordinary General Meetings (EGM) through Video Conferencing (VC) or through other audio-visual means (OAVM). It has also dispensed with certain requirements for listed entities who conduct their AGMs.
CBIC amends its notification Appointment of Customs Airports for specified purposes
The Central Board of Indirect Taxes and Customs (CBIC) published a notification further amending the appointment of customs airports for specified purposes. This present notification was issued on 4th January, 2023. The Central Government has now appointed the airport at Agartala, situated in the State of Tripura, to be Customs airports for the purpose of loading and unloading of baggage.
UGC issues Draft University Grants Commission (Setting up and Operation of Campuses of Foreign Higher Educational Institutions in India) Regulations, 2023
The National Education Policy envisions that top universities in the world will be facilitated to operate in India. Hence UGC has drafted these regulation to facilitate the setting up of campuses of foreign higher educational institutions in India.
Extension of the relaxations from dispatching physical copies of financial statements due in the year 2023
MCA extended the relaxations from dispatching physical copies of financial statements due in the year 2023 till September 30, 2023. The Stock Exchanges are advised to bring the provisions of this circular to the notice of all entities with listed non-convertible securities and disseminate them on their website.
Measures for Onboarding ESIC on the Jeevan Pramaan Portal for Digital Life Certificate
Jeevan Pramaan Project, NIC, New Delhi has been requested to onboard ESIC on the Web portal, so that the facility of generating Digital Life Certificates can be availed by the pensioners and family pensioners of ESIC.
MCA Clarification regarding holding of the Annual General Meeting (AGM) through Video Conference (VC) or Other Audio Visual Means (OAVM)
The companies whose AGMs are due in the Year 2023 can conduct their AGMs on or before September 30, 2023 through Video Conference (VC) or Other Audio Visual Means (OAVM).
Central Electricity Authority (Technical Standards for Construction of Electrical Plants and Electric Lines) Regulations, 2022
These regulations shall apply to generating companies, transmission licensees, distribution licensees, Central Transmission Utilities, and State Transmission Utilities. The regulations provides general requirements of The Electrical Plants and Electric Lines, the Technical Standards for the Construction of Thermal Generating Stations and the technical Standards for the Construction of Hydro-Electric Generating Stations.
IBBI notifies the appointment of a panel of Insolvency Professionals
The Insolvency and Bankruptcy Board of India (IBBI) has issued a public notice for the appointment of a panel of Insolvency Professionals (IPs). The notice was issued for the constitution of the panel for the period from 1st January, 2023 till 30th June, 2023. This panel is created for various zones across the country.
CDSCO notifies inspections/ audits of pharmacovigilance (PV) of importers and manufacturers of human vaccine.
The New Drugs and Clinical Trial Rules, 2019 state that the importer of manufacturer of any new drug for sale and distribution shall have a PV system. The system shall include a place for collecting, processing and forwarding the Adverse Drug Reaction (ADR) reports to the central licensing authority. This information will emerge from the use of the new imported/ manufactured/ marketed drug by the applicant in India.
